Trulieve Cannabis (TSE:TRUL)

Trulieve Cannabis Stock Analysis & Ratings


TRUL Stock Chart & Stats

Day’s RangeC$0 - C$0
52-Week Range― - ―
Previous CloseC$16.9
Average Volume (3M)174.02K
Market CapN/A
Enterprise ValueN/A
P/E Ratio-24.6
Next EarningsNov 14, 2022
EPS Forecast>-C$0.01
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score8
EPS (TTM)-0.69
Shares Outstanding184,219,444
Standard Deviation0.17
10 Day Avg. Volume189,817
30 Day Avg. Volume174,022
P/B Ratio11.14
P/S Ratio2.07
P/CF Ratio162.10
P/FCF Ratio-13.20
Total DebtC$176.73M
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target Upside143.34% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.



What was Trulieve Cannabis’s price range in the past 12 months?
Currently, no data Available
What is Trulieve Cannabis’s market cap?
Currently, no data Available
What is Trulieve Cannabis’s price target?
The average price target for Trulieve Cannabis is C$41.12. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is C$63.71 ,the lowest forecast is C$29.56. The average price target represents 143.34% Increase from the current price of C$16.9.
    What do analysts say about Trulieve Cannabis?
    Trulieve Cannabis’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 9 Wall Streets Analysts.
      When is Trulieve Cannabis’s upcoming earnings report date?
      Trulieve Cannabis’s upcoming earnings report date is Nov 14, 2022 which is in 89 days.
        How were Trulieve Cannabis’s earnings last quarter?
        Trulieve Cannabis released its earnings results on Aug 10, 2022. The company reported -C$0.155 earnings per share for the quarter, missing the consensus estimate of -C$0.01 by -C$0.145.
          Is Trulieve Cannabis overvalued?
          According to Wall Street analysts Trulieve Cannabis’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Trulieve Cannabis pay dividends?
            Trulieve Cannabis does not currently pay dividends.
            What is Trulieve Cannabis’s EPS estimate?
            Trulieve Cannabis’s EPS estimate is >-C$0.01.
              How many shares outstanding does Trulieve Cannabis have?
              Trulieve Cannabis has 135,001,540 shares outstanding.
                What happened to Trulieve Cannabis’s price movement after its last earnings report?
                Trulieve Cannabis reported an EPS of -C$0.155 in its last earnings report, missing expectations of -C$0.01. Following the earnings report the stock price went down -3.488%.
                  Which hedge fund is a major shareholder of Trulieve Cannabis?
                  Currently, no hedge funds are holding shares in TSE:TRUL


                  Trulieve Cannabis Stock Analysis

                  Smart ScoreOutperform
                  The Trulieve Cannabis stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Trulieve Cannabis

                  Trulieve Cannabis Corp. engages in the provision of medical cannabis products. The firm cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. Its products include smokable flower, inhalation, oral, sublingual, topical, inter-nasal, and concentrates. The company was founded on September 21, 2018 and is headquartered in Quincy, FL.

                  Similar Stocks
                  Price & Change
                  Johnson & Johnson
                  Eli Lilly & Co
                  Merck & Company
                  Bristol Myers

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis